Radiation Therapy News and Research RSS Feed - Radiation Therapy News and Research

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
FDA approves new combo treatment for patients with advanced sarcomas

FDA approves new combo treatment for patients with advanced sarcomas

There are approximately 15,000 sarcoma cases annually in the United States, comprising more than 60 types of soft tissue sarcomas and 20 types of bony sarcomas. [More]
World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

World Cancer Congress: DITTA urges development of integrated care approaches in medical technology

In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable. [More]
IDoR 2016 spotlights role of radiology in diagnosis and management of breast diseases

IDoR 2016 spotlights role of radiology in diagnosis and management of breast diseases

On Tuesday, Nov. 8, more than 140 medical societies worldwide will mark the International Day of Radiology, celebrating the thousands of lives saved by the many contributions of breast imagers and radiation oncologists. [More]
High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race/ethnicity, may impact adjuvant endocrine therapy adherence

High out-of-pocket costs, rather than race or ethnicity, are responsible for disparities associated with adherence to adjuvant endocrine therapy, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health. [More]
Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

Penn study reveals new sights into how some intestinal cells can withstand chemotherapy and radiation

When treating cancer with chemotherapy and radiation, decisions about dose must walk a fine line between attacking cancerous cells and preserving healthy ones. [More]
Robot-assisted surgery at NYU Lutheran offers hope to women with endometrial cancer

Robot-assisted surgery at NYU Lutheran offers hope to women with endometrial cancer

Nandi Kumar Carpen, a 51-year-old wife, mother of two young girls, and a nurse at a major city hospital, noticed some "spotty" bleeding outside of her regular menstrual cycle. [More]
Targeting TASINs can be viable approach for preventing colon cancer, research reveals

Targeting TASINs can be viable approach for preventing colon cancer, research reveals

A small molecule called TASIN-1 can selectively kill cells with a mutation that is considered to be a precursor to colon cancer, while sparing related normal cells, UT Southwestern Medical Center cancer biologists have demonstrated. [More]
Yale researchers identify chemical inhibitor that limits growth of lung tumor cells

Yale researchers identify chemical inhibitor that limits growth of lung tumor cells

A recently published Yale study may offer a new solution to fighting lung cancer. [More]
Innovative combined therapy could effectively fight tumors

Innovative combined therapy could effectively fight tumors

Researchers wish to treat tumors more effectively in the future by combining radiation therapy and focused ultrasound. The joint project SONO-RAY began on October 1st, 2016. [More]
Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen. [More]
Increasing incidence of thyroid cancer in past three decades

Increasing incidence of thyroid cancer in past three decades

The incidence of thyroid cancer has tripled in the past three decades, yet the reason for this is not clear. [More]
C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of patients whose prostate cancer returns after surgery. [More]
Researchers identify new strategy to selectively sensitize cancer cells to radiation therapy

Researchers identify new strategy to selectively sensitize cancer cells to radiation therapy

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects. [More]
Study identifies prognostic value of IDH and CIC mutations for grade II/III glioma patients

Study identifies prognostic value of IDH and CIC mutations for grade II/III glioma patients

NRG Oncology investigators have identified two biomarkers that are prognostic of overall and progression-free survival for patients with lower-grade gliomas. [More]
IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Radiation therapy is the main treatment modality in the management of head and neck cancer. [More]
Researchers find better patient-reported quality of life in women who received pelvic IMRT

Researchers find better patient-reported quality of life in women who received pelvic IMRT

NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received standard RT. [More]
Immediate breast reconstruction can help avoid period of psychosocial distress linked to mastectomy

Immediate breast reconstruction can help avoid period of psychosocial distress linked to mastectomy

Immediate breast reconstruction (IBR) can avoid some of the psychological effects of undergoing mastectomy for breast cancer, compared to waiting for delayed breast reconstruction (DBR), reports a study in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons. [More]
Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

Study examines benefits of hormonal therapy for prostate cancer patients with prior history of heart attack

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. [More]
Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Stereotactic body radiation therapy (SBRT) is a specialized and highly targeted method of delivering radiotherapy, or radiation therapy, to treat cancer. [More]
Study helps identify optimal treatment option for NSCLC patients with brain metastases

Study helps identify optimal treatment option for NSCLC patients with brain metastases

A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment. [More]
Advertisement
Advertisement